Company Filing History:
2 out of 41 
2 out of 5,076 
1 out of 153 
Years Active: 2014-2023
Title: Innovator Christophe Arnoult: Advancing Animal Reproductive Technologies
Introduction: Christophe Arnoult, an accomplished inventor based in Saint Etienne de Crossey, France, has made significant contributions to the field of animal reproductive technology. With three patents to his name, Arnoult is dedicated to enhancing the fertility and motility of animal sperm through innovative methods and applications.
Latest Patents: One of Arnoult's latest inventions is a method for increasing the lifespan and motility of animal sperm by using an inhibitor of the Slo3 potassium channel. This invention outlines a novel approach where sperm is contacted with this specific inhibitor, aiming to enhance its lifespan and motility. Additionally, the invention provides insights into an artificial insemination instrument designed for use in the artificial insemination of animals, which incorporates sperm treated with the Slo3 potassium channel inhibitor. Another notable patent involves the use of La1-like peptide isolated from Maurus palmatus venom as an activator of sperm motility in mammals. This non-toxic agent is beneficial for treating male infertility in humans and enhancing fertility in animals. It holds promise in various artificial reproductive techniques, including in vitro fertilization (IVF) and intra-cytoplasmic sperm injection (ICSI), as well as in artificial insemination techniques like intra-cytoplasmic uterine injection (IUI).
Career Highlights: Christophe Arnoult has a rich career, collaborating with renowned institutions like IMV Technologies and Université Joseph Fourier. His work has had a substantial impact on both animal and human reproductive technologies, paving the way for new methodologies in the field.
Collaborations: Throughout his career, Arnoult has worked alongside esteemed colleagues such as Eric Schmitt and Guillaume Martinez. Their collective expertise has contributed to the development and refinement of innovative solutions in reproductive technologies.
Conclusion: Christophe Arnoult stands out as a leading figure in advancing animal reproductive technology. His inventive spirit and groundbreaking patents not only contribute to the scientific community but also hold the potential for improving fertility treatments in both animals and humans. As his research continues to evolve, Arnoult remains a pioneer in the quest for enhanced reproductive solutions.